Sentinel lymph node mapping using methylene blue and Technetium-99 in early endometrial cancer
Background: Endometrial cancer (EC) is the most prevalent genital related cancer of females. One of the controversial points about endometrial cancer surgery is preserving or dissection of sentinel lymph nodes (SLNs). Lymphatic mapping and sentinel nodes sample has been used widely for diverse solid...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | fas |
Published: |
Tehran University of Medical Sciences
2017-11-01
|
Series: | Tehran University Medical Journal |
Subjects: | |
Online Access: | http://tumj.tums.ac.ir/browse.php?a_code=A-10-25-5626&slc_lang=en&sid=1 |
id |
doaj-dd8ab0b0a1f84fe194ee3bc390330671 |
---|---|
record_format |
Article |
spelling |
doaj-dd8ab0b0a1f84fe194ee3bc3903306712020-11-24T23:00:42ZfasTehran University of Medical SciencesTehran University Medical Journal1683-17641735-73222017-11-01758570576Sentinel lymph node mapping using methylene blue and Technetium-99 in early endometrial cancerFariba Behnamfar0Matina Jafari1Masoud Moslehi2 Department of Obstetrics and Gynecology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran. Department of Obstetrics and Gynecology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran. Department of Nuclear Medicine, Isfahan University of Medical Sciences, Isfahan, Iran. Background: Endometrial cancer (EC) is the most prevalent genital related cancer of females. One of the controversial points about endometrial cancer surgery is preserving or dissection of sentinel lymph nodes (SLNs). Lymphatic mapping and sentinel nodes sample has been used widely for diverse solid tumors in order of finding metastasis in lymph nodes. The aim of current study was to evaluate diagnostic value of technetium-99 and methylene blue in diagnosis of sentinel lymph node involvement in low-risk endometrial cancer. Methods: This cross-sectional study was conducted through 2016 on 14 patients with low-grade endometrial cancer referred to Al-Zahra and Shahid Beheshti Hospitals (affiliated to Isfahan University of Medical Sciences), Iran, in 2016-17. Eighteen and twenty-four hours before operation, patients underwent technetium-99 (Tc-99) injection to uterine cervix. Twenty-four hours prior to surgery, patients were referred to resident of gynecology and filled demographic checklist. In next day during operation, Tc-99 was detected by gamma probe. Methylene blue was injected in operation room and blue nodes were detected by naked eye. All patients underwent total hysterectomy, bilateral salpingo-oophorectomy and pelvic lymphadenectomy. Dissected lymph nodes were sent for frozen section and assessment of positive/negative metastasis. Then data were analyzed with SPSS software, version 20 (SPSS Inc., Chicago, IL, USA). Results: Mean age of our patients was 60.64±9.18 years. Total number of 80 SLNs was dissected. 18.8% of nodes were detected using methylene blue, 12.5% using tecnethium-99 and 6.3% were in common with both methods. Number of two nodes was metastatic and was detected by blue dye and Tc-99. Sensitivity, negative predictive value and detection rate of Tc-99 alone, methylene blue alone and their combination was 100% and false negativity of all above was 100%. Conclusion: Due to findings of our study, as sensitivity, detection rate, negative predictive value and false negativity of methods lonely and in combination were similar thus based on higher probability of blue dye adverse effects, use of Tc-99 lonely may be adequate. http://tumj.tums.ac.ir/browse.php?a_code=A-10-25-5626&slc_lang=en&sid=1endometrial cancer methylene blue sentinel lymph node technetium-99 |
collection |
DOAJ |
language |
fas |
format |
Article |
sources |
DOAJ |
author |
Fariba Behnamfar Matina Jafari Masoud Moslehi |
spellingShingle |
Fariba Behnamfar Matina Jafari Masoud Moslehi Sentinel lymph node mapping using methylene blue and Technetium-99 in early endometrial cancer Tehran University Medical Journal endometrial cancer methylene blue sentinel lymph node technetium-99 |
author_facet |
Fariba Behnamfar Matina Jafari Masoud Moslehi |
author_sort |
Fariba Behnamfar |
title |
Sentinel lymph node mapping using methylene blue and Technetium-99 in early endometrial cancer |
title_short |
Sentinel lymph node mapping using methylene blue and Technetium-99 in early endometrial cancer |
title_full |
Sentinel lymph node mapping using methylene blue and Technetium-99 in early endometrial cancer |
title_fullStr |
Sentinel lymph node mapping using methylene blue and Technetium-99 in early endometrial cancer |
title_full_unstemmed |
Sentinel lymph node mapping using methylene blue and Technetium-99 in early endometrial cancer |
title_sort |
sentinel lymph node mapping using methylene blue and technetium-99 in early endometrial cancer |
publisher |
Tehran University of Medical Sciences |
series |
Tehran University Medical Journal |
issn |
1683-1764 1735-7322 |
publishDate |
2017-11-01 |
description |
Background: Endometrial cancer (EC) is the most prevalent genital related cancer of females. One of the controversial points about endometrial cancer surgery is preserving or dissection of sentinel lymph nodes (SLNs). Lymphatic mapping and sentinel nodes sample has been used widely for diverse solid tumors in order of finding metastasis in lymph nodes. The aim of current study was to evaluate diagnostic value of technetium-99 and methylene blue in diagnosis of sentinel lymph node involvement in low-risk endometrial cancer.
Methods: This cross-sectional study was conducted through 2016 on 14 patients with low-grade endometrial cancer referred to Al-Zahra and Shahid Beheshti Hospitals (affiliated to Isfahan University of Medical Sciences), Iran, in 2016-17. Eighteen and twenty-four hours before operation, patients underwent technetium-99 (Tc-99) injection to uterine cervix. Twenty-four hours prior to surgery, patients were referred to resident of gynecology and filled demographic checklist. In next day during operation, Tc-99 was detected by gamma probe. Methylene blue was injected in operation room and blue nodes were detected by naked eye. All patients underwent total hysterectomy, bilateral salpingo-oophorectomy and pelvic lymphadenectomy. Dissected lymph nodes were sent for frozen section and assessment of positive/negative metastasis. Then data were analyzed with SPSS software, version 20 (SPSS Inc., Chicago, IL, USA).
Results: Mean age of our patients was 60.64±9.18 years. Total number of 80 SLNs was dissected. 18.8% of nodes were detected using methylene blue, 12.5% using tecnethium-99 and 6.3% were in common with both methods. Number of two nodes was metastatic and was detected by blue dye and Tc-99. Sensitivity, negative predictive value and detection rate of Tc-99 alone, methylene blue alone and their combination was 100% and false negativity of all above was 100%.
Conclusion: Due to findings of our study, as sensitivity, detection rate, negative predictive value and false negativity of methods lonely and in combination were similar thus based on higher probability of blue dye adverse effects, use of Tc-99 lonely may be adequate.
|
topic |
endometrial cancer methylene blue sentinel lymph node technetium-99 |
url |
http://tumj.tums.ac.ir/browse.php?a_code=A-10-25-5626&slc_lang=en&sid=1 |
work_keys_str_mv |
AT faribabehnamfar sentinellymphnodemappingusingmethyleneblueandtechnetium99inearlyendometrialcancer AT matinajafari sentinellymphnodemappingusingmethyleneblueandtechnetium99inearlyendometrialcancer AT masoudmoslehi sentinellymphnodemappingusingmethyleneblueandtechnetium99inearlyendometrialcancer |
_version_ |
1725641368625217536 |